Global Guideline for Type 2 Diabetes (2012)
All people with diabetes should have access to the broad range of diabetes services and therapies and no person should be denied any element of effective diabetes care. It is recognised that in many parts of the developing world the implementation of particular standards of care is limited by lack of resources. This guideline provides a practical approach to promote the implementation of cost-effective evidence-based care in settings between which resources vary widely.
The Global IDF/ISPAD Guidelines for Diabetes in Childhood and Adolescence (2011)
These Guidelines have been developed to improve awareness among governments, state health care providers and the general public of the serious long-term implications of poorly managed diabetes and of the essential resources needed for optimal care and to assist individual care givers in managing children and adolescents with diabetes in a prompt, safe, consistent, equitable, standardised manner in accordance with the current views of experts in the field.
Management of Postmeal Glucose in Diabetes (2011)
The purpose of this guideline is to consider the evidence on the relationship between postmeal glucose and glycaemic control (HbA1c). Based on this information, recommendations for the appropriate management and monitoring of postmeal glucose in type 1 and type 2 diabetes have been developed.
The recommendations are intended to assist clinicians and organizations in developing strategies to consider and effectively manage postmeal glucose in people with type 1 and type 2 diabetes, taking into consideration locally available therapies and resources. Although the literature provides valuable information and evidence regarding this area of diabetes management, uncertainties remain about a causal association between postmeal plasma glucose and complications and additional research is needed to clarify our understanding in this area. Logic and clinical judgement remain critical components of diabetes care and implementation of any guideline recommendations.
Oral Health for People with Diabetes (2009)
Maintenance of proper oral hygiene for good oral health is an accepted part of the normal recommendations for a healthy lifestyle. Poor oral hygiene is associated with gingivitis, which can progress to more severe infection and inflammation leading to periodontitis. Infectious disease is known to be more common in people with diabetes if blood glucose control is poor, and inflammation is known to be associated with a decrease in insulin sensitivity and thus potentially a worsening of blood glucose control.
The International Diabetes Federation and the World Dental Federation came together under the lead of the IDF Task Force on Clinical Guidelines to address whether the evidence base in this area allowed formal recommendations on oral health and diabetes care to be made. The result of the collaboration between the two organizations is the IDF Guideline on Oral Health for People with Diabetes.
Pregnancy and Diabetes (2009)
Pregnancy is associated with changes in insulin sensitivity which may lead to changes in plasma glucose levels. For women with known diabetes or for women who develop diabetes during the pregnancy, these changes can put outcomes at risk. This guideline deals with the means of identifying women for whom such problems are new, and helping them, as well as women already known to have diabetes, to achieve the desired outcome of a healthy mother and baby.
Self-monitoring of Blood Glucose in Non-insulin Treated Type 2 Diabetes (2009)
In 2008, the International Diabetes Federation Clinical Guidelines Task Force, in conjunction with the Self-monitoring of Blood Glucose International Working Group convened a workshop in Amsterdam to address the issue of Self-monitoring of Blood Glucose utilization in people with type 2 diabetes (T2M) who are not treated with insulin. The IDF Guideline on Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes presents a summary of the findings and recommendations of the workshop. Findings from studies of SMBG used in non-insulin treated T2DM have been inconsistent due to differences in study designs, populations, and interventions used. However, the data available from randomized controlled trials (RCTs) suggest that SMBG is likely to be an effective self-management tool only when results are reviewed and acted upon by healthcare providers and/or people with diabetes to actively modify behavior and/or adjust treatment.